A biotech startup headquartered in Durham has added fresh funding to its seed round.
The company, Tiamat Sciences, this month announced a $2 million seed extension to a financing round first disclosed in 2021. The company is developing animal-free recombinant proteins that can be used in cellular agriculture, regenerative medicine and vaccine production.
This additional funding brings Tiamat's seed round total to $5.4 million after the company disclosed its initial $3 million raise in November…
